Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 464Melanoma 300Squamous Cell Carcinoma of Head and Neck 234Parkinson Disease 4, Autosomal Dominant Lewy Body 189Neoplasms 185Triple Negative Breast Neoplasms 163Breast Neoplasms 162Neoplasm Metastasis 157Lung Neoplasms 147Colorectal Neoplasms 142Carcinoma, Renal Cell 132Head and Neck Neoplasms 123Stomach Neoplasms 104Ovarian Neoplasms 101Carcinoma, Transitional Cell 91Urinary Bladder Neoplasms 81Pancreatic Neoplasms 81Endometrial Neoplasms 74Carcinoma, Hepatocellular 74Uterine Cervical Neoplasms 63Esophageal Neoplasms 57Recurrence 52Prostatic Neoplasms 49Sarcoma 43Carcinoma 42Glioblastoma 40Small Cell Lung Carcinoma 39Carcinoma, Squamous Cell 39Hodgkin Disease 36Cholangiocarcinoma 35

Interventions

Methotrexate 6Dactinomycin 6Drug Therapy 4camrelizumab 3Vacuum Curettage 3Flow Cytometry 3toripalimab 2pembrolizumab 2apatinib 2Psychiatric Rehabilitation 2Methylprednisolone 2Leucovorin 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclophosphamide 2Carboplatin 2Alemtuzumab 2zimberelimab 1sargramostim 1dostarlimab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carotuximab 1aldesleukin 1Vincristine 1Thrombopoietin 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × pembrolizumab × Clear all
NCT05635344 2024-04-17

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Imperial College London

Phase 2 Recruiting
20 enrolled
Gynecologic

Recurrence, Gestational Trophoblastic Disease

NCT04303884 2020-03-11

CR-GTP

CHA University

Phase 2 Unknown
15 enrolled
Gynecologic

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡